The elevated expression of osteopontin and NF-κB in human aortic aneurysms and its implication

Abstract

The expression and significance of osteopontin (OPN) and NF-κB in patients with thoracic aortic aneurysm (TAA) and abdominal aortic aneurysm (AAA) were investigated. Thirteen TAA specimens, 20 AAA specimens and 6 normal aortic specimens were collected. The expression of OPN, nuclear factor-κB P65 (NF-κB P65), urokinase plasminogen activator (uPA), matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9) were detected by using immunohistochemistry and Western blotting was employed to determine the expression of OPN and NF-κB P65. Immunohistochemical results showed that the expression of OPN, NF-κB P65, uPA, MMP-2 and MMP-9 was positive in all TAA and AAA specimens and negative in normal specimens, with the difference being statistically significant (P<0.05). There was no difference in the expression between TAA and AAA specimens (P>0.05). Correlation analysis revealed that there existed a positive correlation between the expression of OPN and that of NF-κB P65, uPA, MMP-2 and MMP-9 and between the expression of NF-κB P65 and that of uPA, MMP-2, MMP-9 (P<0.05). Western blotting demonstrated that OPN and NF-κB P65 were positive in AAA and TAA specimens, and negative in normal specimens with the differences being statistically significant (P<0.05). There were no statistically significant differences in the expression of OPN and NF-κB P65 between AAA and TAA specimens (P>0.05). It was concluded that OPN and NF-κB P65 were involved in the pathogenesis of TAA and AAA. OPN can up-regulate the expression of MMP and uPA via NF-κB signaling pathway thereby accelerating the degradation of extracellular matrix and playing an important role in the pathogenesis and development of TAA and AAA.

Keywords

aortic aneurysm / osteopontin / NF-κB / matrix metalloproteinase

References

[1] SakalihasanN., LimetR., DefaweO.D.. Abdominal aortic aneurysm. Lancet, 2005, 365(9470): 1577-1589

[2] GrangeJ.J., DavisV., BaxterB.T.. Pathogenesis of abdominal aortic aneurysm: an update and look toward the future. Cardiovasc Surg, 1997, 53: 256-265

[3] LongoG.M., XiongW., GreinerT.C., et al.. Matrix metallo-Proteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin lnvest, 2002, 110(5): 625-632

[4] AzizF., KuivaniemiH.. Role of matrix metalloproteinase inhibitors in preventing abdominal aortic aneurysm. Ann Vasc Surg, 2007, 21(3): 392-401

[5] XiongW., KnispelR., MactaggartJ., et al.. Membrane-type 1 matrix metalloproteinase regulates macrophage-dependent elastolytic activity and aneurysm formation in vivo. J Biol Chem, 2009, 284(3): 1765-1771

[6] WilsonW.R., AndertonM., ChokeE.C., et al.. Elevated plasma MMP1 and MMP9 are associated with abdominal aortic aneurysm rupture. Eur J Vasc Endovasc Surg, 2008, 35(5): 580-584

[7] Jean ClaudeJ., NewmanK.M., LiH. e. a1.. Possible key role for plasmin in the pathogenesis of abdominal aortic aneurysms. Surgery, 1994, 116(2): 472-478

[8] PhilipS., KunduG.C.. Osteopontin induces nuclear factor kappa B-mediated promatrix metalloproteinase-2 activation through I kappa B alpha/IKK signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways. J Biol Chem, 2003, 278(16): 14487-14497

[9] PhilipS., BulbuleA., KunduG.C.. Osteopontin stimulates tumor growth and activation of promatrix metallopr oteinase-2 through nuclear factor-kappa B-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells. J Biol Chem, 2001, 276(48): 44926-44935

[10] DasR., PhilipS., MahabeleshwarG.H., et al.. Osteopontin: it’s role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression. IUBMB Life, 2005, 57(6): 441-447

[11] LiuS.J., HuG.F., LiuY.J., et al.. Effect of human osteopontin on proliferation, transmigration and expression of MMP-2 and MMP-9 in osteosarcoma cells. Chin Med J (Engl), 2004, 117(2): 235-240

[12] RangaswamiH., BulbuleA., KunduG.C.. Osteopontin: role in cell signaling and cancer progression. Trends Cell Biol, 2006, 16(2): 79-87

[13] RodriguesL.R., TeixeiraJ.A., SchmittF.L., et al.. The role of osteopontin in tumor progression and metastasis in breast cancer. Cancer Epidemiol Biomarkers Prev, 2007, 16(6): 1087-1097

[14] WaiP.Y., KuoP.C.. Osteopontin: regulation in tumor metastasis. Cancer Metastasis Rev, 2008, 27(1): 103-118

[15] BruemmerD., CollinsA.R., NohG., et al.. Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice. J Clin Invest, 2003, 112(9): 1318-1331

[16] NakashimaH., AokiM., MiyakeT., et al.. Inhibition of experimental abdominal aortic aneurysm in the rat by use of decoy oligodeoxynucleotides suppressing activity of nuclear factor kappaB and ets transcription factors. Circulation, 2004, 109(1): 132-138

[17] ShanahanC.M., WeissbergP.L., MetcalfeJ.C.. Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells. Circ Res, 1993, 73(1): 193-204

[18] WuJ.-q., JingZ.-ping.. Phenotypic changes of vascular smooth muscle cells in human abdominal aortic aneurysms. Chin J Pathophysiol (Chinese), 2003, 9(5): 595-598

[19] IsodaK., KamezawaY., AyaoriM., et al.. Osteopontin transgenic mice fed a high-cholesterol diet develop early fatty-streak lesions. Circulation, 2003, 107(5): 679-681

[20] JuvonenJ., SurcelH.M., SattaJ., et al.. Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic ameurysm. Arterioscler Thromb Vasc Biol, 1997, 17(11): 2843-2847

[21] HalpernV.J., NackmanG.B., GranhiR.H., et al.. The elastase infusion model of experimental aortic aneurysms: Synchrony of induction of endogenous proteinases with matrix destruction and inflammatory cell response. J Vasc Surg, 1994, 20(1): 51-60

[22] O’ReganA.W., ChuppG.L., LowryJ.A., et al.. Osteopontin is associated with T cells in sarcoid granulomas and has T cell adhesive and cytokine-like properties in vitro. J Immunol, 1999, 162(2): 1024-1031

[23] LentschA.B., WardP.A.. Activation and regulation of NFkappaB during acute inflammation. Clin Chem Lab Med, 1999, 37(3): 205-208